The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Value Expansion Is Expected For The Cell Viability Assays Market Over The Forecast Period?
The cell-free dna isolation and extraction market size has experienced significant expansion in recent years. This market is projected to grow from $2.05 billion in 2025 to $2.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. The factors contributing to this growth in the historic period include the increasing adoption of liquid biopsy techniques, a rise in molecular diagnostics testing, the expansion of prenatal screening programs, the growing use of genomic research tools, and the availability of specialized extraction kits.
The cell-free dna isolation and extraction market size is anticipated to experience substantial growth over the coming years. It is projected to reach $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. This expansion during the forecast period is primarily driven by factors such as the heightened demand for early cancer detection, increasing investments in precision diagnostics, the broadening of transplant monitoring applications, the growing integration of automation in molecular laboratories, and an escalating focus on rapid and accurate cfDNA workflows. Key trends expected in this period include a wider adoption of non-invasive genetic testing workflows, the rising utilization of magnetic bead-based extraction technologies, an expanding demand for automated cfDNA isolation systems, the broader application in oncology and prenatal testing, and an enhanced emphasis on high-yield DNA recovery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp
What Core Drivers Are Transforming The Cell Viability Assays Market?
The increasing incidence of cancer is projected to fuel the expansion of the Cell-Free DNA Isolation And Extraction Market in the future. Cancer describes a severe category of illnesses marked by the uncontrolled proliferation and dissemination of abnormal cells, frequently forming tumors that can invade other body parts, impair normal bodily functions, and, if untreated, lead to severe illness or fatality. The rise in cancer cases is linked to factors such as the obesity epidemic, inherited genetic defects, hepatitis B and C viruses, Epstein-Barr virus (EBV), and human papillomavirus (HPV). Cell-free DNA (cfDNA) extraction and isolation methods enable thorough genomic analysis for cancer, providing crucial insights into tumor biology, responses to treatment, and disease progression. These methods hold the potential to transform cancer management by facilitating early detection, tailored treatment strategies, and better patient outcomes. For instance, in May 2024, data from the American Society of Clinical Oncology, a US-based professional organization, indicated that approximately 20 million new cancer cases were diagnosed in 2022, with this number anticipated to reach 35 million by 2050, leading to an estimated 9.7 million deaths attributed to the disease. Consequently, the rising prevalence of cancer is a primary driver for the growth of the Cell-Free DNA Isolation And Extraction Market.
Cell-Free DNA Isolation And Extraction Market Driver: Role Of Personalized Medicine In Expanding The Cell-Free DNA Isolation And Extraction Market
How Is The Cell Viability Assays Market Examined Through Segment Analysis?
The cell viability assays market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates
2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems
Which Trends Are Shaping The Cell Viability Assays Market Landscape?
Leading companies in the cell-free DNA isolation and extraction market are focusing on creating innovative products, specifically automated DNA extraction instruments, to gain a competitive edge. These automated DNA extraction instruments are advanced laboratory devices designed to simplify and automate the procedure of isolating DNA from various biological samples. For instance, in September 2023, Yourgene Health plc, a UK-based molecular diagnostics company, launched the MagBench Automated DNA Extraction Instrument and Kit to enhance its Sage 32 NIPT workflow across Asia-Pacific and the Middle East. This pioneering solution offers several distinct features crafted to streamline and improve the DNA extraction process for prenatal screening. The MagBench instrument combines automation with accuracy, utilizing magnetic bead-based technology to efficiently isolate high-quality DNA from maternal blood samples.
Which Organizations Are Operating Within The Cell Viability Assays Market?
Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.
Access The Complete Cell Viability Assays Market Report:
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report
Which Region Leads The Cell Viability Assays Market By Size?
North America was the largest region in the cell viability assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Cell Viability Assays Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp
Browse Through More Reports Similar to the Global Cell Viability Assays Market 2026, By The Business Research Company
Stem Cells Therapy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Cellulars Immunotherapy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report
Cell And Genes Therapy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model